Authors


Heidi C. Waters, MBA

Latest:

Rheumatoid Arthritis and Joint Replacement: Impact of Biologics

Since the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.


Jessica L. Kerr, PharmD, CDE

Latest:

Sodium-Glucose Co-Transporter-2 Inhibitors: An Update on the Evidence for Treatment of Type 2 Diabetes

Sodium-glucose co-transporter-2 inhibitors are a class of antihyperglycemic agents that can be used to improve glycemic control in the treatment of type 2 diabetes.


Aimee Simone, Assistant Editor

Latest:

Job Loss Fears May Raise Asthma Risk

Those who fear they will lose their jobs have an increased risk of developing incident asthma.


Chiou-Fang Chiou, PhD

Latest:

Claims Data Analysis of Dosing and Cost of TNF Antagonist

Higher drug costs may be attributable to either high initial doses or a dose increase.


Ali Din

Latest:

The Cloud Is Casting Its Welcome Shadow on the Pharmaceutical Industry

Pharmacies may be able to achieve significant savings and operational efficiencies with the cloud.


Bethany Rettberg, NPC

Latest:

Discuss Adverse Effects of Vaping With Patients

They may mistakenly believe that e-cigarettes are safe and wonder why they cause a cough.


Kristen Bunnell, PharmD, BCCCP

Latest:

New Antimicrobials Expand Treatment Options

Eravacycline, Omadacycline, Plazomicin, and a Rifamycin Add to the Armamentarium for Treating Resistant Infections


Erin N. Deja, PharmD Candidate

Latest:

Death With Dignity: A Right or a Crime?

Five states—Oregon, Washington, Vermont, Colorado, and California—and the District of Columbia now have Death With Dignity acts.



Vaishali D. Patel, PharmD

Latest:

Claims Data Analysis of Dosing and Cost of TNF Antagonist

Higher drug costs may be attributable to either high initial doses or a dose increase.


Jason M. Broderick

Latest:

Cabozantinib Granted FDA Approval for Advanced HCC

The FDA has approved cabozantinib (Cabometyx, Exelixis) as a treatment for patients with hepatocellular carcinoma (HCC) who previously received sorafenib (Nexavar, Bayer).


Louis F. McIntyre, MD

Latest:

Impact of Hyaluronic Acid Injections on Pain Management Medications Utilization

This study assessed the impact of initiating hyaluronic acid injections on pain management pharmacotherapies utilization patterns in patients with knee osteoarthritis.


Roger A. Santos, PharmD

Latest:

National Panel Updates Its Asthma Guideline

The National Asthma Education and Prevention Program's Expert Panel has issued revised guidelines for treating asthma in children and adults.


Kyle Skiermont, PharmD

Latest:

Indecision Is Not an Option: Understanding the Range of Business Models for Health-System Specialty Pharmacy

When planning for a specialty pharmacy within a health system, 3 business models should be considered: build, partner, and outsource.


Sandra Goldstein, RN

Latest:

Cost Outcomes of Diabetes Education in a Specialized Community Pharmacy

Diabetes management offered by an employer group in a self-funded health plan over 3 years resulted in significant cost savings and improved patient outcomes.


Georgia Burnett, Creative Design Technician, QS/1

Latest:

Pharmacies Expand Through Deliveries and Providing Vaccinations

Providing vaccinations to patients and offering delivery services are excellent ways for pharmacies to grow their business.


Jennifer Powers, PharmD, Senior Manager, Patient Care

Latest:

The Role of the Pharmacist as Part of a Multidisciplinary Cancer Care Team

The high-level monitoring required for self-managing patients with cancer becomes a challenge when patients are seen less frequently by their provider.


Stacey Ruf, PhD

Latest:

Prescription Utilization by Multiple Sclerosis Patients in the United States

Future costs of MS therapy are likely to increase due to new add-on therapy combined with double-digit growth in utilization for existing drugs.


Kent C. Hunter, PharmD

Latest:

The Value-Based Model: Health Management Worth Exploring

The author broadly discusses the concept of value-based insurance design and provides examples of three corporations that have implemented this benefit model.



Kirk McKay

Latest:

Leading by Examples of Value over Volume

At the American Pharmacists Association 2017 meeting, an inspiring and practical session titled “Leading by Example” showed how pharmacists can leverage their value to establish health care team partnerships (eg, with health systems and physician practices) and implement programs to win pharmacy “champions,” improve patient outcomes, and reduce health care costs.



Edward Read, MD

Latest:

Prescription Opioid Overdose: Providing a Safeguard for At-Risk Patients

A new combination drug-device product uses novel technology.


Erica L. Wegrzyn, PharmD

Latest:

Carefully Assess Bleeding Risk in Patients on Antidepressants

SSRIs have been shown to inhibit reuptake of serotonin in platelets, ultimately impairing platelet aggregation.


Bruce Kneeland, Community Pharmacy Specialist

Latest:

Pharmacy Owners, Managers Turning to Outside Help to Boost Profits

Several pharmacy owners are working with innovative companies that have new products, effective programs, or innovative services that address these issues, and when implemented make it possible to their pharmacy to be profitable.


Laurie Wade, PharmD Candidate

Latest:

Sweet Dreams: A Guide to Overcoming Insomnia

When insomnia begins to negatively impact a patient's quality of life, pharmacists can explain the nonpharmalogic and pharmalogic treatment options.


Dillion Barbour, PharmD

Latest:

Cannabidiol Products' Impact on Pharmacist-Provided Medication Management

Pharmacists can assist with advising patients who present with quality concerns to use CBD products that provide certificates of analyses, and catch significant drug interactions before they occur.


Adam Martin, PharmD, ACSM-CPT

Latest:

Obesity Is a Weight-Loss Maintenance Problem

The prevalence of obesity has reached 39.8% of Americans, affecting 93.3 million of US adults.


Hongkai Bao, PharmD

Latest:

It Is a "VRE" Serious Controversy

What are the advantages and disadvantages of linezolid versus daptomycin for vancomycin-resistant enterococcus bacteremia?


Krisy-Ann Thornby, PharmD

Latest:

Diabetes Apps: Impacting Patients' Lives

A new wave of mobile applications encourages disease management on the go.